Trademark: 90092381
Status Date
Monday, September 26, 2022
Filing Date
Tuesday, August 4, 2020
Published for Opposition
Tuesday, June 29, 2021
Abandoned Date
Monday, September 26, 2022
5 Pharmaceuticals and therapeutic pharmaceuticals for the treatment and prevention of cancer and hematological diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, neurodegenerative diseases and disorders, cardiac diseases and disorders, infectious diseases and disorders, skin and hair diseases and disorders, ear or nose or throat diseases and disorders, orthopedic diseases and disorders, respiratory diseases and disorders, reproductive diseases and disorders, gastrointestinal diseases and disorders
42 Research and development of pharmaceuticals and therapeutics
Sep 26, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Sep 26, 2022
Abandonment - No Use Statement Filed
Feb 25, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 23, 2022
Sou Extension 1 Granted
Feb 23, 2022
Sou Extension 1 Filed
Feb 23, 2022
Teas Extension Received
Aug 24, 2021
Noa E-Mailed - Sou Required From Applicant
Jun 29, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 29, 2021
Published For Opposition
Jun 9, 2021
Notification Of Notice Of Publication E-Mailed
May 21, 2021
Approved For Pub - Principal Register
May 20, 2021
Teas/Email Correspondence Entered
May 19, 2021
Correspondence Received In Law Office
May 19, 2021
Teas Response To Office Action Received
Feb 3, 2021
Automatic Update Of Assignment Of Ownership
Nov 23, 2020
Notification Of Non-Final Action E-Mailed
Nov 23, 2020
Non-Final Action E-Mailed
Nov 23, 2020
Non-Final Action Written
Nov 23, 2020
Assigned To Examiner
Sep 3, 2020
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24
